Blood-brain barrier P-glycoprotein function in neurodegenerative disease

AL Bartels - Current pharmaceutical design, 2011 - ingentaconnect.com
Protection of the brain is strengthened by active transport and ABC transporters. P-
glycoprotein (P-gp) at the blood-brain barrier (BBB) functions as an active efflux pump by …
被引用次数：112 相关文章

[引用][C] Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease

AL BARTELS - Current pharmaceutical design (Print), 2011 - pascal-francis.inist.fr
Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Blood-brain barrier P-glycoprotein function in neurodegenerative disease

AL Bartels - Current pharmaceutical design, 2011 - pubmed.ncbi.nlm.nih.gov
Protection of the brain is strengthened by active transport and ABC transporters. P-
glycoprotein (P-gp) at the blood-brain barrier (BBB) functions as an active efflux pump by …

Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease

AL Bartels - Current Pharmaceutical Design, 2011 - research.rug.nl
Protection of the brain is strengthened by active transport and ABC transporters. P-
glycoprotein (P-gp) at the blood-brain barrier (BBB) functions as an active efflux pump by …

Blood-brain barrier P-glycoprotein function in neurodegenerative disease.

AL Bartels - Current Pharmaceutical Design, 2011 - europepmc.org
Protection of the brain is strengthened by active transport and ABC transporters. P-
glycoprotein (P-gp) at the blood-brain barrier (BBB) functions as an active efflux pump by …

[引用][C] Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease

AL BARTELS - Current pharmaceutical design, 2011 - Bentham